AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05456256 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carboplatin
Description: Carboplatin: area under the concentration-time curve 5 mg/mL per minute (AUC5) by intravenous (IV) infusion over 30 minutes, administered every 21 days for a total of 4 to 6 treatment cycles. The number of treatment cycles will be determined by PI discretion.
Study NCT04753528 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AuriMod CT01_A
Description: AuriMod CT01 is a wearable medical device for personalised pain treatment through auricular vagus nerve stimulation. AuriMod CT01 is a battery-operated electrical stimulation device, to be placed behind the ear on the neck. AuriMod CT01 connects to three needle electrodes, which are placed in vagally innervated regions of the auricle. It emits electrical signals with a personalized set of stimulation parameters and adjustable amplitude.
Study NCT04753528 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: AuriMod CT01_B
Description: AuriMod CT01 with a fixed set of stimulation parameters and adjustable stimulation amplitude.
Study NCT04753528 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: AuriMod CT01_C
Description: AuriMod CT01 with a fixed set of stimulation parameters and amplitude.
Study NCT05965310 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Virtual Psychological Intervention: Cognitive Behavioral Therapy
Description: An asynchronous course of pre- and post-operative CBT modules (VPI) will be delivered to patients in Group A as an adjuvant treatment to standard-of-care rehabilitation.
Study NCT05395936 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Myocardial Probe Temperature Screen
Description: The myocardial probe is a needle that measures temperatures. The skin site for introducing the myocardial probe will be small enough that participants will not notice that temperatures have been collected. If participants have multiple operations, temperatures may be collected at each operation.
Study NCT05395936 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Data Collection
Description: Study team members will collect medical history and other information to potentially understand the safety and success of breast surgery better to allow investigators to identify variables, or changes to help understand investigators roles in potential complications in breast surgery.
Study NCT06558071 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Galatonol 300 mg/Striatin 30 mg
Description: 1 film-coated caplet of Herba Asimor, twice daily
Study NCT06558071 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 1 film-coated caplet of placebo Herba Asimor, twice daily
Study NCT01890941 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KCT-0809 ophthalmic solution
Study NCT04835181 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Electroacupuncture combined with umbilical moxibustion
Description: ①Umbilical moxibustion intervention: point selection: Shenque point Operation: Place the aconite cake on the Shenque point, place the Aizhu in the middle of the aconite cake, ignite the Aizhu and apply moxibustion to make the local warm sensation without burning pain, until the skin is flushed.~②Electro-acupuncture intervention: Acupoint selection: Tianshu, Zusanli, Zhongwan, Moisture, Daheng, Vein, Waterway, Huaroumen, Abdominal Knot.~Operation: supine position, routine skin disinfection. After routine acupuncture at the acupoints, apply the technique of flattening, replenishing, relieving, and relieving qi. Tianshu and Daheng points, respectively, were horizontally connected to the electrodes of the electroacupuncture instrument on the needle handles of the bilateral Tianshu and Daheng points.~Electroacupuncture parameters: density wave, current intensity 1-5mA, electroacupuncture intensity is subject to patient tolerance.
Study NCT04835181 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Electroacupuncture
Description: ②Electro-acupuncture intervention: Acupoint selection: Tianshu, Zusanli, Zhongwan, Moisture, Daheng, Vein, Waterway, Huaroumen, Abdominal Knot.~Operation: supine position, routine skin disinfection. After routine acupuncture at the acupoints, apply the technique of flattening, replenishing, relieving, and relieving qi. Tianshu and Daheng points, respectively, were horizontally connected to the electrodes of the electroacupuncture instrument on the needle handles of the bilateral Tianshu and Daheng points.~Electroacupuncture parameters: density wave, current intensity 1-5mA, electroacupuncture intensity is subject to patient tolerance.
Study NCT04989010 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 89Zr-NY005
Description: 89Zr-NY005 injection followed by 89Zr-NY005 PET scan
Study NCT06460688 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mother Rehabilitative Aid Education Program
Description: Routine neuro physical therapy will be given which includes Stretching, truck control and independent transition, train standing and activation of base, gain walking with minimal assistance, Gain ground clearance with stair climbing. A class will be organized to educate Mothers/ Caregivers through PPT presentation, video and pictures. This class will contain 3 domains (Counseling, Educating, Practicing). Feedback will be taken on daily basis through video recordings. Mothers will take part in treatment session, 45 minutes for 5 days a week for 8 weeks.
Study NCT06460688 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Neuro physical Therapy
Description: Routine neuro physical therapy will be given which includes Stretching, truck control and independent transition, train standing and activation of base, gain walking with minimal assistance, Gain ground clearance with stair climbing. for 45 minutes, 5 days a week for 8 weeks. Participants in group B will not be educated about treatment plan. Routine home plan was given in this group once in a week, for 8 weeks.
Study NCT06150287 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Florajen Digestion
Description: Florajen Digestion is a probiotics. One probiotics capsule contains 15 billion Colony Forming Unit (CFU) of live microorganisms. No live microorganisms are present in the placebo capsules.
Study NCT01890941 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT05384886 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Polymerase chain reaction
Description: Covid-19 genetic material detection from mouth and nose swab
Study NCT06558396 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ACE intervention
Description: Participants attend the ACE Program for 12 weeks after school. On one assigned day of the week, participants attend ACE in person after school. The session begins with mindfulness exercises (20 minutes), nutrition education lesson/cooking lab (65 minutes, odd weeks) OR professional development session (65 minutes, even weeks). On any day during the 2-week cooking period, the students will make a dish using groceries they received with their parent/guardian (1 hour).
Study NCT05469035 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mobile-based video
Description: Nurses in the experimental group participated in mobile-based video learning.
Study NCT05469035 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Face-to-face
Description: Nurses in the experimental group participated in face-to-face learning.
Study NCT06150287 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Florajen Digestion
Description: Florajen Digestion is a probiotics. One probiotics capsule contains 15 billion Colony Forming Unit (CFU) of live microorganisms. No live microorganisms are present in the placebo capsules.
Study NCT06016920 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VB10.16
Description: Intramuscular (i.m.) administrations of VB10.16 every 3 weeks (Q3W) starting at Week 1/Day 1 during a 12-week induction period, followed by a maintenance period with administrations every 6 weeks (Q6W) from Week 13 until Week 48. A total of up to 10 i.m. administrations will be given.~VB10.16 will be administered via Pharma Jet® Stratis 0.5 mL needle free injection system.
Study NCT06141928 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Functional recovery analysis
Description: Functional recovery analysis with force evaluator \& tester
Study NCT06647641 — intervention group
Intervention type: OTHER
Intervention: Whole genome sequencing will be performed at the NIH
Description: All samples will undergo non-CLIA approved whole genome sequencing on a research basis in collaboration with Sonja Scholz, MD, PhD at the Neurodegenerative Diseases Research Unit of the National Institutes of Health (Bethesda, MD). This sequencing method allows for the identification of not only variants known to be associated with these disorders but also potentially novel variants.
Study NCT05838651 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: MinerOss® X Plug
Description: A xenograft composed of 80% bovine cancellous particulate and 20% bovine Type I collagen.
Study NCT05838651 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: MinerOss® X Plug
Description: A xenograft composed of 80% bovine cancellous particulate and 20% bovine Type I collagen.
Study NCT05838651 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Striate+ Membrane
Description: A non-crosslinked collagen covering used to keep bacteria out and hold the bone graft in place.
Study NCT05640791 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: 25mg/m2；d1, 8, 21 d cycle
Study NCT05640791 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine
Description: 1000mg/m2；d1, 8, 21 d cycle
Study NCT05640791 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: 100mg/m2；d1, 8, 21 d cycle
Study NCT05640791 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: 1000mg；d1, 21 d cycle
Study NCT05722795 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Imatinib 400 MG Oral Tablet
Description: One tablet daily 10 days before surgery.
Study NCT05553678 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Description: Midazolam (0.03 mg/kg/30 min) will administered during UIA clipping through microscope.
Study NCT05553678 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Normal saline
Description: Normal saline (0.03 mg/ml/30 min) will administered during UIA clipping through microscope.
Study NCT06220630 — intervention group
Intervention type: OTHER
Intervention: Breast cancer
Description: Male patients who were microscopically diagnosed as primary breast cancer.
Study NCT06364332 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Social Media campaign
Description: Participants receive content three times a week; in total 24 pieces of content in 8 weeks. The content can consist of one or more photos or images with a caption (explanation in text).
Study NCT06364332 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Social Media campaign
Description: Participants receive content three times a week; in total 24 pieces of content in 8 weeks. The content can consist of one or more photos or images with a caption (explanation in text).
Study NCT04801108 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Robotic or VATS lobar fissure completion
Description: The lobar fissure adjacent to the target lobe will be completed using a surgical stapler through robotic or video-assisted thoracic surgery.
Study NCT04801108 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Endobronchial valves placement
Description: Endobronchial valves will be placed in the target lobe after the fissure completion.
Study NCT06260579 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Exercise/physical activity
Description: personalized exercise training and physical activity program
Study NCT06260579 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise/physical activity
Description: personalized exercise training and physical activity program
Study NCT06164145 — intervention group
Intervention type: OTHER
Intervention: Usual care
Description: The training program used in this study is the stroke rehabilitation program focusing on health education for stroke and a routine exercise program based on the National Strategic Plan for Stroke Rehabilitation in Myanmar.
Study NCT05464862 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Popliteal Plexus Block with 10 ml
Description: Ultrasound-guided Popliteal Plexus Block using 10 ml of of Lidocaine Hydrochloride 10 mg/ml
Study NCT05464862 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Popliteal Plexus Block with 20 ml
Description: Ultrasound-guided Popliteal Plexus Block using 20 ml of of Lidocaine Hydrochloride 10 mg/ml
Study NCT05464862 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Popliteal Plexus Block with 30 ml
Description: Ultrasound-guided Popliteal Plexus Block using 30 ml of of Lidocaine Hydrochloride 10 mg/ml
Study NCT05464862 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Femoral Nerve Block
Description: Ultrasound-guided Femoral Nerve Block using 20 ml of of Lidocaine Hydrochloride 10 mg/ml. Is used to find cut-off values that define affection of the femoral nerve.
Study NCT05464862 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sciatic Nerve Block
Description: Ultrasound-guided Sciatic Nerve Block using 20 ml of of Lidocaine Hydrochloride 10 mg/ml. Is used to find cut-off values that define affection of the sciatic nerve.
Study NCT05837052 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: serplulimab plus chemotherapy as conversion treatment
Description: Patients with unresectable NSCLC will receive serplulimab plus chemotherapy as conversion treatment, and then curative pneumonectomy will be provided for patients who are suitable for primary tumor resection. Locoregional ablative treatments will be performed for metastatic lesions.
Study NCT04350190 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Apatinib mesylate tablet
Description: The dose of apatinib mesylate tablets is 250mg, oral, qd, continuous administration, 4 weeks (28 days) as an observation cycle.
Study NCT04350190 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PD-1
Description: The dose of PD - 1 is 200 mg/ time, intravenous injection, q2w, 4 weeks (28 days) for an observation period.
Study NCT02503176 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: KCT-0809 ophthalmic solution
Study NCT04903964 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: family-centered nutrition education
Description: There is a training program prepared by the researcher to increase the nutritional knowledge of mothers with children aged 0-3. The definition and importance of nutrition in the session, respectively, adequate and balanced nutrition, insufficient and unbalanced nutrition damages, grouping of nutrients, feeding 0--6 months old baby, feeding premature baby, breastfeeding, situations to be considered while breastfeeding, starting additional foods, 9-12 monthly baby nutrition, 1-3 years old child nutrition and nutritional nutrition support.
Study NCT04969133 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Levobupivacaine Hydrochloride 2.5 MG/ML
Description: To compare TAP block versus local infiltration of the trocar wounds with levobupivacaine 2.5 mg/ml for post operative pain relief after laparoscopic appendicectomy in children
Study NCT05902546 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: High intensity interval training
Description: Patients will receive interval training exercise of high intensity. This includes several rounds that alternate between several minutes of high intensity movements to significantly increase the heart rate to at least 80% of one's maximum heart rate, followed by short periods of rest
Study NCT05902546 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: moderate intensity aerobic exercise
Description: Patients will receive moderate intensity continuous aerobic exercise (walking) for 40 minutes (preceded by 10 minutes warming up and followed by 5 minutes cooling down)
Study NCT05189158 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Hypercapnic hyperoxic ventilatory response
Description: The hypercapnic ventilatory response (HCVR) described by Read in 1967 (Read's rebreathing method) is a clinical way to assess the central and peripheric sensitivity to CO2, using a small bag (4-6 l) to achieve prompt equilibrium between the apparatus compartments and the lungs.~By rebreathing a hyperoxic mixture with an initial composition of 70% O2, 7% CO2 and 23% N2, this equilibrium is assumed to be achieved after 15 seconds of rebreathing, when the relationship between VE and PetCO2 has become linear.
Study NCT05189158 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Hypoxic eucapnic ventilatory response
Description: The hypoxic eucapnic ventilatory response (HOVR) is a clinical way to assess the peripheric chemosensitivity to O2, using a small bag (4-6 l) to rebreathe a gas mixture initially composed of 20% O2, 0% CO2 and Δ% N2. Eucapnia is achieved by the activation of a CO2 reabsorption cell during the course of the test.
Study NCT05403749 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: dose 1 IBI302
Description: After 4 loading monthly intravitreal injections of dose 1 IBI302，the following IBI302 IVT is given as descript in protocol.
Study NCT05403749 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Aflibercept
Description: Three consecutive monthly intravitreal injections of 2.0mg Aflibercept followed by injection every other month
Study NCT05403749 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: dose 2 IBI302
Description: After 4 loading monthly intravitreal injections of dose 2 IBI302，the following IBI302 IVT is given as descript in protocol
Study NCT06273306 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: IMIDOC
Description: Patient´s Mobile App for recording clinical data
Study NCT05834764 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pyrotinib
Description: Pyrotinib after anti-HER2 therapy（Trastuzumab combined with Pertuzumab or T-DM1）
Study NCT05341505 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Emotion Regulation Intervention
Description: We will administer a cognitive-behavioral treatment targeting emotion dysregulation, including mindfulness skills and other cognitive and behavioral emotion regulation skills.
Study NCT05998954 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: transmuscular quadratus lumborum and modified erector spinae plane (QLESP) block
Description: Fifteen ml of 0.375% ropivacaine was administered between the erector spinae muscle and the transverse process. Fifteen ml of 0.375% ropivacaine was subsequently given between the quadratus lumborum and the psoas major muscles.
Study NCT05998954 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: suprainguinal fascia iliaca block
Description: Thirty ml of 0.375% ropivacaine will be injected cranial to the inguinal ligament between the fascia iliaca and the iliopsoas muscle.
Study NCT05593159 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Dentin Conditioning
Description: After washing and drying -but not desiccating- Dentin Conditioner 20% (GC, Japan) will be applied using a cotton pellet for 20 seconds then rinsed thoroughly and gently dried
Study NCT05593159 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: RM-GIC
Description: RM-GIC (Fuji II LC) will be applied in \<2mm incremental layers afterword light-cured for 10 sec (1,000 mW/cm2) per increment to fill the cavity.
Study NCT05593159 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 1-step adhesive
Description: A universal adhesive system (Tetric® N-Bond Universal) will be applied on both enamel and dentin and gently scraped for 20 sec, then dispersed with oil-free gentle air stream, then light-cured for 10 sec (1,000 mW/cm2).
Study NCT05154266 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Taking it Further
Description: This programme is offered to individuals who have already completed a Mindfulness-Based Cognitive Therapy (MBCT) or Mindfulness-Based Stress Reduction Programme (MBSR). In this programme, participants explore weekly themes (i.e. 'Responding not reacting' and 'Taking care of ourselves, taking care of others'). These themes reinforce the learning from the eight-week MBCT/MBSR courses whilst also providing new learning opportunities. The programme makes some of the dimensions that are implicit in MBCT/MBSR more explicit; for example, the cultivation of attitudes of mindfulness (such as equanimity, joy, and kindness). These attitudes of mindfulness require a foundational mindfulness practice and thus this is an additive learning theme from traditional MBCT/MBSR programmes.
Study NCT06522581 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Citicoline Sodium
Description: one group of neonates with confirmed HIE grade II and III will receive injection citicoline through IV route within 06 hours of birth
Study NCT06522581 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Citicoline Sodium
Description: one group of neonates with confirmed HIE grade II and III will receive injection citicoline through IV route within 06 hours of birth
Study NCT06491628 — intervention group
Intervention type: BEHAVIORAL
Intervention: Avoiding the risk factors
Description: Exercise, Salt and lipid reduction in diet, smoking cessation